PROC Procaps
- 2.700
- -0.075-2.70%
Procaps News
Procaps Group: Matters Involve Historical Acctg Treatment and Associated Fincl Statement Disclosure Related to 2012 Loan >PROC
Procaps Group: Matters Involve Historical Acctg Treatment and Associated Fincl Statement Disclosure Related to 2012 Loan >PROC
Procaps Group Working to Complete Fincl Statements to File Form 20-F Before May 15 >PROC
Procaps Group Working to Complete Fincl Statements to File Form 20-F Before May 15 >PROC
Procaps Group Cites Internal Investigation Initiated by Audit Committee >PROC
Procaps Group Cites Internal Investigation Initiated by Audit Committee >PROC
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Group Delays Filing of Annual Report on Form 20-F
Procaps Group S.A. (NASDAQ:PROC) Insiders Have Significant Skin in the Game With 60% Ownership
Softgel Capsules Market Size, Share & Trends Analysis Report 2023-2030, Featuring Fuji Capsule, Sirio Pharma, CAPTEK Softgel, Catalent, EuroCaps, Aenova, ProCaps Laboratories and Soft Gel Technologies
A Look Into Healthcare Sector Value Stocks
Understanding Value StocksA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indica
Procaps Explores Strategic Alternatives to Boost Shareholder Value
Procaps Announces Formation Of Strategic Committee To Explore Value Creation Alternatives
Procaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategi
Procaps Group S.A.'s (NASDAQ:PROC) Top Key Executive Ruben Minski Is the Most Upbeat Insider, and Their Holdings Increased by 14% Last Week
Key Insights Significant insider control over Procaps Group implies vested interests in company growth A total of 3 investors have a majority stake in the company with 60% ownership Ownership rese
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. Shares of Ecolab Inc. (NYSE:ECL) rose during Tuesday's session after the company reported better-than-expecte
Procaps Group Appoints Jose Vieira as CEO
Procaps Issues Shareholder Letter From New CEO
Procaps Group (NASDAQ:PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira, CEO of Procaps. Dear
Procaps Group Provides Notice To Shareholders; Says On Saturday, January 13, 2024, That The Online Voting Instructions Related To The Upcoming General Meeting Of Shareholders Of The Company Scheduled For January 22, 2024, Were Incorrect
Dear Shareholders,We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 20
Procaps Group – Notice to Shareholders
Dear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 2024, were
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors ar
Financial Results Led A Surge In Procaps (PROC) Stock
Procaps Group S.A. (NASDAQ: PROC) witnessed a notable upswing of 13.71% in its stock value, concluding the trading session at $3.98 on Tuesday. This positive momentum can be attributed to the disclosure of its quarterly financial results. For the fiscal third quarter ending on September 30, 2023 ("3Q23"), Procaps (PROC) unveiled its financial performance, revealing ...
Pharma Company Procaps Beats On Q3 But Lowers FY23 Guidance: Here's Why
Procaps Group SA (NASDAQ:PROC) reported Q3 FY23 revenue of $118.41 million, beating the consensus of $110.4 million and rose 7% Y/Y (+2% Y/Y in constant currency), led by the performance of RX and OTC
Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Coherus BioSciences, Inc. (NASDAQ:CHRS) reported the FDA approva
Procaps Group Reports Q3 Results; Updates FY23 Outlook
Analysis
Price Target
No Data
